Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 15 studies | 33% ± 13% | |
peripheral blood | 15 studies | 28% ± 9% | |
intestine | 9 studies | 28% ± 14% | |
kidney | 8 studies | 30% ± 9% | |
brain | 7 studies | 29% ± 15% | |
eye | 5 studies | 29% ± 11% | |
lymph node | 4 studies | 27% ± 11% | |
breast | 4 studies | 23% ± 7% | |
liver | 4 studies | 36% ± 16% | |
pancreas | 3 studies | 42% ± 20% | |
bone marrow | 3 studies | 26% ± 6% | |
uterus | 3 studies | 40% ± 18% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
adrenal gland | 100% | 3754.53 | 258 / 258 | 100% | 354.89 | 230 / 230 |
liver | 100% | 4363.25 | 226 / 226 | 100% | 327.23 | 406 / 406 |
esophagus | 100% | 2525.36 | 1441 / 1445 | 100% | 158.81 | 183 / 183 |
intestine | 100% | 3226.05 | 966 / 966 | 99% | 276.44 | 522 / 527 |
brain | 100% | 6656.93 | 2639 / 2642 | 99% | 179.50 | 699 / 705 |
uterus | 99% | 2499.59 | 169 / 170 | 100% | 207.47 | 457 / 459 |
stomach | 100% | 3183.62 | 359 / 359 | 99% | 228.54 | 283 / 286 |
ovary | 99% | 3111.17 | 178 / 180 | 100% | 211.45 | 430 / 430 |
prostate | 100% | 6320.73 | 244 / 245 | 99% | 516.12 | 498 / 502 |
thymus | 98% | 2596.83 | 642 / 653 | 100% | 200.59 | 605 / 605 |
skin | 100% | 2761.87 | 1801 / 1809 | 99% | 220.24 | 466 / 472 |
bladder | 100% | 3241.86 | 21 / 21 | 98% | 239.92 | 493 / 504 |
kidney | 100% | 3735.51 | 89 / 89 | 97% | 190.42 | 876 / 901 |
breast | 100% | 3174.48 | 457 / 459 | 97% | 194.60 | 1089 / 1118 |
lung | 97% | 2330.51 | 558 / 578 | 97% | 149.02 | 1126 / 1155 |
pancreas | 87% | 1244.51 | 285 / 328 | 98% | 189.44 | 175 / 178 |
eye | 0% | 0 | 0 / 0 | 100% | 319.39 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 322.40 | 29 / 29 |
spleen | 100% | 2887.27 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 177.20 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 235.54 | 1 / 1 |
heart | 100% | 8779.04 | 858 / 861 | 0% | 0 | 0 / 0 |
muscle | 100% | 5724.15 | 800 / 803 | 0% | 0 | 0 / 0 |
adipose | 100% | 3402.34 | 1198 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 98% | 2251.14 | 1307 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 60% | 959.15 | 558 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006412 | Biological process | translation |
GO_0006915 | Biological process | apoptotic process |
GO_0032543 | Biological process | mitochondrial translation |
GO_0005762 | Cellular component | mitochondrial large ribosomal subunit |
GO_0005739 | Cellular component | mitochondrion |
GO_1990904 | Cellular component | ribonucleoprotein complex |
GO_0005743 | Cellular component | mitochondrial inner membrane |
GO_0003735 | Molecular function | structural constituent of ribosome |
GO_0005515 | Molecular function | protein binding |
GO_0003723 | Molecular function | RNA binding |
Gene name | MRPL41 |
Protein name | Large ribosomal subunit protein mL41 (39S ribosomal protein L41, mitochondrial) (L41mt) (MRP-L41) (Bcl-2-interacting mitochondrial ribosomal protein L41) (Cell proliferation-inducing gene 3 protein) (MRP-L27 homolog) |
Synonyms | BMRP MRPL27 RPML27 PIG3 |
Description | FUNCTION: Component of the mitochondrial ribosome large subunit . Also involved in apoptosis and cell cycle . Enhances p53/TP53 stability, thereby contributing to p53/TP53-induced apoptosis in response to growth-inhibitory condition. Enhances p53/TP53 translocation to the mitochondria. Has the ability to arrest the cell cycle at the G1 phase, possibly by stabilizing the CDKN1A and CDKN1B (p27Kip1) proteins . . |
Accessions | Q8IXM3 ENST00000371443.6 |